ACCURX LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +30%

  £37,370,636 → £48,584,831

• Cash

  +9.4%

  £25,517,290 → £27,927,368

• Net assets

  +6.5%

  £26,202,531 → £27,905,596

• Employees

  -10.1%

  248 → 223

• Operating profit

  +99.4%

  -£11,046,829 → -£64,805

• Profit before tax

  +107.3%

  -£10,439,243 → £758,882

• Wages

  -9.6%

  £19,219,859 → £17,366,479

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Cooper Parry Group Limited

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The directors have prepared projected cash flow information in excess of 12 months from the date of their approval of these financial statement. The detailed projections demonstrate the company is forecast to remain cash positive and accordingly the directors believe the company has adequate resources to continue in operational existence for the period of at least 12 months from the date of the approval of these financial statements.”

Significant events

• “The company's core focus has expanded into two major strategic initiatives powered by artificial intelligence (AI): the development and commercialisation of an ambient scribing tool across primary and secondary care settings, and the launch of a Digital Front Door (DFD) solution to manage and divert primary care demand.”
• “Key activities undertaken during the period include continued efforts toward product convergence and platform unification, and the sustained focus on service expansion and innovation. The company demonstrated market leadership and convening by hosting major user events, including a central conference in May 2025.”
• “Commercial expansion continued with the securing of large-scale contracts with Integrated Care Boards (ICBs) in England and geographical expansion, notably securing the company's first health board contract in Scotland.”
• “a ransomware attack observed at a customer organisation in February 2025.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

20

last 12 months

Capital events

10

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.